Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly
The clinical potential of peptide therapeutic agents can only be fully realised once their physicochemical and pharmacokinetic properties are precisely controlled. Here the authors show a reversible peptide self-assembly strategy to control and prolong the bioactivity of a native peptide hormone in...
Enregistré dans:
Auteurs principaux: | Myriam M. Ouberai, Ana L. Gomes Dos Santos, Sonja Kinna, Shimona Madalli, David C. Hornigold, David Baker, Jacqueline Naylor, Laura Sheldrake, Dominic J. Corkill, John Hood, Paolo Vicini, Shahid Uddin, Steven Bishop, Paul G. Varley, Mark E. Welland |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c7f770bfea9c44cf8e0311310d874e5d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biocompatibility pathways and mechanisms for bioactive materials: The bioactivity zone
par: David F. Williams
Publié: (2022) -
Plant-Based Colloidal Delivery Systems for Bioactives
par: Yunbing Tan, et autres
Publié: (2021) -
Fruit Derived Potentially Bioactive Bioengineered Silver Nanoparticles
par: Baker A, et autres
Publié: (2021) -
A universal reporter cell line for bioactivity evaluation of engineered cytokine products
par: Jacqueline Mock, et autres
Publié: (2020) -
The bone hormones and their potential effects on glucose and energy metabolism
par: Addai Daniel, et autres
Publié: (2019)